Huron Consulting Group (NASDAQ:HURN) Stock Price Down 3.6% - Should You Sell?

Huron Consulting Group Inc. (NASDAQ:HURN - Get Free Report)'s share price was down 3.6% during mid-day trading on Wednesday . The stock traded as low as $135.91 and last traded at $134.98. Approximately 43,386 shares were traded during trading, a decline of 72% from the average daily volume of 153,395 shares. The stock had previously closed at $140.09.

Wall Street Analyst Weigh In

Several research analysts recently issued reports on HURN shares. Wall Street Zen cut shares of Huron Consulting Group from a "buy" rating to a "hold" rating in a report on Friday, May 2nd. Benchmark reaffirmed a "buy" rating and issued a $165.00 price objective on shares of Huron Consulting Group in a report on Wednesday, March 26th. Truist Financial lifted their price objective on shares of Huron Consulting Group from $165.00 to $180.00 and gave the company a "buy" rating in a report on Tuesday, March 4th. Barrington Research boosted their target price on shares of Huron Consulting Group from $167.00 to $173.00 and gave the stock an "outperform" rating in a research note on Monday, May 5th. Finally, Wedbush boosted their target price on shares of Huron Consulting Group from $150.00 to $165.00 and gave the stock an "outperform" rating in a research note on Wednesday, March 26th. One equities research analyst has rated the stock with a hold rating and five have issued a buy rating to the stock. According to data from MarketBeat, the company has an average rating of "Moderate Buy" and an average target price of $170.75.

Huron Consulting Group Stock Up 1.2%

The stock has a market capitalization of $2.36 billion, a price-to-earnings ratio of 29.69 and a beta of 0.30. The business's 50-day moving average is $143.69 and its two-hundred day moving average is $135.53. The company has a quick ratio of 1.61, a current ratio of 1.61 and a debt-to-equity ratio of 0.82.

Huron Consulting Group (NASDAQ:HURN - Get Free Report) last posted its earnings results on Tuesday, April 29th. The business services provider reported $1.68 earnings per share for the quarter, beating the consensus estimate of $1.16 by $0.52. The company had revenue of $404.14 million for the quarter, compared to analyst estimates of $389.27 million. Huron Consulting Group had a net margin of 5.80% and a return on equity of 21.51%. Huron Consulting Group's revenue was up 11.2% on a year-over-year basis. During the same period in the previous year, the business posted $1.23 EPS. Equities analysts anticipate that Huron Consulting Group Inc. will post 6.1 EPS for the current year.

Insider Transactions at Huron Consulting Group

In other Huron Consulting Group news, Director John Mccartney sold 500 shares of the stock in a transaction that occurred on Tuesday, April 1st. The shares were sold at an average price of $142.67, for a total value of $71,335.00. Following the sale, the director now directly owns 52,121 shares of the company's stock, valued at approximately $7,436,103.07. This represents a 0.95% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, Director James H. Roth sold 8,641 shares of the stock in a transaction that occurred on Wednesday, March 26th. The shares were sold at an average price of $142.38, for a total transaction of $1,230,305.58. Following the completion of the sale, the director now directly owns 47,638 shares in the company, valued at approximately $6,782,698.44. This represents a 15.35% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 18,951 shares of company stock worth $2,758,473. 2.15% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Huron Consulting Group

Large investors have recently modified their holdings of the company. Summit Investment Advisors Inc. boosted its holdings in shares of Huron Consulting Group by 5.5% in the 4th quarter. Summit Investment Advisors Inc. now owns 1,838 shares of the business services provider's stock valued at $228,000 after buying an additional 96 shares in the last quarter. Wealth Enhancement Advisory Services LLC boosted its holdings in shares of Huron Consulting Group by 3.1% in the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 4,039 shares of the business services provider's stock valued at $502,000 after buying an additional 121 shares in the last quarter. Tower Research Capital LLC TRC boosted its holdings in shares of Huron Consulting Group by 27.3% in the 4th quarter. Tower Research Capital LLC TRC now owns 569 shares of the business services provider's stock valued at $71,000 after buying an additional 122 shares in the last quarter. CWM LLC boosted its holdings in shares of Huron Consulting Group by 55.9% in the 1st quarter. CWM LLC now owns 407 shares of the business services provider's stock valued at $58,000 after buying an additional 146 shares in the last quarter. Finally, Nisa Investment Advisors LLC boosted its holdings in shares of Huron Consulting Group by 15.6% in the 1st quarter. Nisa Investment Advisors LLC now owns 1,094 shares of the business services provider's stock valued at $157,000 after buying an additional 148 shares in the last quarter. 93.90% of the stock is owned by hedge funds and other institutional investors.

About Huron Consulting Group

Huron Consulting Group Inc, a professional services firm, provides consultancy services in the United States and internationally. It operates through three segments: Healthcare, Education, and Commercial. The Healthcare segment provides financial and operational performance improvement consulting services; digital offerings, spanning technology and analytic-related services; software products; organizational transformation services; revenue cycle managed and outsourcing services; financial and capital advisory consulting services; and strategy and innovation consulting services to national and regional health systems, academic and community health systems, federal health system, public, children's and critical access hospitals, physician practices and medical groups, payors, and long-term care or post-acute providers.